Home › Attention Deficit Hyperactivity Disorder › Florida › Jacksonville
Attention Deficit Hyperactivity Disorder clinical trials in Jacksonville, FL
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
RecruitingPhase 3
- CNS Healthcare - Jacksonville (Clinical Neuroscience Solutions - Jacksonville), Jacksonville
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Clinical Neuroscience Solutions, Inc., Jacksonville
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Jacksonville
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Jacksonville
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Philadelphia, PA6 studies
- Austin, TX6 studies
- Washington, DC5 studies
- Pittsburgh, PA5 studies
- Orlando, FL5 studies
- Las Vegas, NV5 studies
- Los Angeles, CA4 studies
- Atlanta, GA4 studies
- Baltimore, MD4 studies
- Durham, NC4 studies
Other studies in Jacksonville
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer40 studies
- Cancer (all types)30 studies
- Metastatic Cancer28 studies
- Colorectal Cancer27 studies
- Prostate Cancer26 studies
- Obesity24 studies
- Pancreatic Cancer22 studies
- Heart Failure21 studies
- Overweight18 studies
- Multiple Myeloma18 studies
- Lung Cancer17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.